加速结核病新疫苗研发:全球路线图
为消除结核病,亟需一种有效且可负担的新疫苗,尤其供中低收入国家成人和青少年使用。本文通过参与式流程制定路线图,列出加速结核病疫苗研发所需行动,涵盖疫苗管线多样性、临床开发加速、公共卫生影响评估、投资与开放科学等。
要点
- 需更多样化的免疫学方法、抗原和平台以丰富疫苗管线。
- 验证的临床前模型、商定的保护相关物、高效试验设计和验证终点可加速临床开发。
- 需增加研发投资、资助来源多样性及资助方协调,并加强产业参与和政治承诺。
核心结论
- 为全球消除结核病,亟需一种新的、有效且可负担的疫苗,尤其用于中低收入国家的成人和青少年。
研究设计与样本
- 通过参与式流程制定路线图,列出加速结核病疫苗研发所需的行动。
主要发现
- 疫苗管线需要更多样化的免疫学方法、抗原和平台。
- 临床开发可通过验证的临床前模型、商定的实验室保护相关物、高效试验设计和验证终点加速。
- 确定新结核病疫苗的公共卫生影响需了解国家对新型疫苗的需求、如何将疫苗实施与现行结核病预防工作整合、成本及国家和全球需求以刺激疫苗生产。
- 需增加结核病疫苗研发投资,扩大资助来源多样性并加强资助方之间的协调。
- 开放科学对提高研发效率很重要,包括早期免费发表研究结果及有效共享数据集和标本的机制。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To eliminate tuberculosis globally, a new, effective, and affordable vaccine is urgently needed, particularly for use in adults and adolescents in low-income and middle-income countries. We have created a roadmap that lists the actions needed to accelerate tuberculosis vaccine research and development using a participatory process. The vaccine pipeline needs more diverse immunological approaches, antigens, and platforms. Clinical development can be accelerated by validated preclinical models, agreed laboratory correlates of protection, efficient trial designs, and validated endpoints. Determining the public health impact of new tuberculosis vaccines requires understanding of a country's demand for a new tuberculosis vaccine, how to integrate vaccine implementation with ongoing tuberculosis prevention efforts, cost, and national and global demand to stimulate vaccine production. Investments in tuberculosis vaccine research and development need to be increased, with more diversity of funding sources and coordination between these funders. Open science is important to enhance the efficiency of tuberculosis vaccine research and development including early and freely available publication of study findings and effective mechanisms for sharing datasets and specimens. There is a need for increased engagement of industry vaccine developers, for increased political commitment for new tuberculosis vaccines, and to address stigma and vaccine hesitancy. The unprecedented speed by which COVID-19 vaccines have been developed and introduced provides important insight for tuberculosis vaccine research and development.
引用
- Cobelens F, Suri RK, Helinski M, et al. Accelerating research and development of new vaccines against tuberculosis: a global roadmap. Lancet Infect Dis. 2022. PMID: 35240041. doi:10.1016/S1473-3099(21)00810-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。